Ceribell anticipates 2026 revenue between $114 million and $117 million, as the Centers for Medicare & Medicaid Services (CMS) finalizes its New Technology Add-on Payment (NTAP) for delirium, potentially reaching up to $2,171 per patient.

Orthofix shares surged after the Centers for Medicare & Medicaid Services (CMS) announced a policy change regarding non-invasive bone growth stimulators. This regulatory update is expected to positively impact the company's market position.

The Centers for Medicare & Medicaid Services (CMS) has put forward a proposal to make Medicare drug price negotiations a permanent fixture.

Sanuwave Health (SNWV) experienced a stock decline following a decision by the Centers for Medicare & Medicaid Services (CMS) to drop a coverage limit.

Inspire Medical's stock surged after KeyBanc indicated that the Centers for Medicare & Medicaid Services (CMS) is expected to add codes for the Inspire V implant.

Orthofix Medical (OFIX) is seeing positive market reaction after the Centers for Medicare & Medicaid Services (CMS) reversed its previous reimbursement cut, making the company's stock appear more attractive.

Orthofix Medical's stock saw an increase following a reversal by the Centers for Medicare & Medicaid Services (CMS) regarding non-invasive bone growth stimulators.

Clover Health (CLOV) shares reached a new peak following an unexpected positive rating from the Centers for Medicare & Medicaid Services (CMS).

EHC shares gained after the Centers for Medicare & Medicaid Services (CMS) announced an increase in payment rates, which was met with approval by investors.

Oracle Cloud Infrastructure is gaining traction after being selected by the Centers for Medicare & Medicaid Services (CMS).

More insurers are filing lawsuits against the Centers for Medicare & Medicaid Services (CMS) over the Medicare Advantage star ratings system, citing a 'broken' system.

The Centers for Medicare & Medicaid Services (CMS) is recalculating Medicare Advantage star ratings after losing a lawsuit filed by Clover Health, though the adjustment is not expected to be a universal benefit for all plans.

The Centers for Medicare & Medicaid Services (CMS) is reportedly planning to tighten regulations on state Medicaid funding, potentially leaving many hospitals across the nation vulnerable to financial strain.

Organogenesis anticipates a substantial revenue decline of 25%-38% by 2026, attributing the projected decrease to market disruption driven by policy changes from the Centers for Medicare & Medicaid Services (CMS).